Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
Recruiting · NCT07128303 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-08-19 | NCT07128303 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| NEXT Virginia | Fairfax | United States | 83 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| START - Centro Oncológico Clara Campal | Madrid | Spain | 1 |
| START Madrid - FJD - Hospital Fundación Jiménez Díaz - Phase I Clinical Trials Unit | Madrid | Spain | 1 |
| START San Antonio | San Antonio | United States | 30 |
| Vall d'Hebron Institute of Oncology (VHIO) | Barcelona | Spain | 7 |
| Yonsei University Severance Hospital | Seoul | South Korea | 1 |